receptor antagonist

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8546452
APP PUB NO 20090170895A1
SERIAL NO

12088861

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to arylamidrazone derivatives having an antagonistic action against S1P3 receptors represented by the following formula (1) or a pharmaceutically acceptable salt thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TOA EIYO LTDCHUO-KU TOKYO 104-0032

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hasegawa, Takeshi Fukushima, JP 111 1031
Ohnuma, Shin-ya Chuo-ku, JP 2 0
Sada, Tomoyuki Saitama, JP 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 1, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00